Is cosentyx a dmard?

Is Cosentyx considered a DMARD?

Cosentyx (secukinumab) is not a traditional DMARD like methotrexate or sulfasalazine. It’s a targeted biologic medicine (a “biologic DMARD”) used to treat several inflammatory autoimmune diseases, especially those involving skin and joint inflammation. [1]

What makes it a biologic DMARD?

Cosentyx is an immunomodulating drug that targets a specific inflammatory pathway (it blocks interleukin-17A). Because it’s used to treat immune-mediated inflammatory conditions and can reduce disease activity, it falls under the broader category of biologic DMARDs. [1]

How is it different from “conventional” DMARDs?

Conventional DMARDs (like methotrexate) affect the immune system more broadly, while biologic DMARDs like Cosentyx are more specific in what they block. In practice, both are used as disease-controlling treatments in conditions such as psoriatic arthritis and ankylosing spondylitis, but they are different drug types. [1]

Where does Cosentyx fit in common treatment plans?

Cosentyx is used for inflammatory arthritis and related immune conditions; whether it’s used as a first-line vs later therapy depends on the condition and how prior treatments have worked, including other DMARDs or biologics. [1]

Sources:
[1] https://www.drugs.com/cosentyx.html